RetinalGenix Technologies (RTGN) Other Operating Expenses (2020 - 2026)
RetinalGenix Technologies (RTGN) reported Other Operating Expenses of $210016.0 for Q1 2026, down 9.45% on a YoY basis from $231933.0 in Q1 2025, and down 25.33% sequentially from $281246.0 in Q4 2025.
RetinalGenix Technologies (RTGN) Other Operating Expenses (2020 - 2026) Analysis & Trends
RetinalGenix Technologies (RTGN) has 7 years of Other Operating Expenses data on file, last reported at $210016.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Operating Expenses fell 9.45% year-over-year to $210016.0; the trailing twelve-month figure through Mar 2026 stood at $1.0 million (down 8.14% YoY), and the FY2025 full-year result was $1.0 million, down 60.13% from the prior year.
- Other Operating Expenses slipped to $210016.0 in Q1 2026, from $281246.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $2.1 million in Q3 2022 to a low of $55051.0 in Q1 2022.
- A 5-year average of $400987.8 and a median of $231933.0 in 2025 frame the typical range for Other Operating Expenses.
- Across the five-year window, Other Operating Expenses jumped 3721.14% in 2022 and slumped 86.62% in 2025, its largest moves.
- Tracing RTGN's Other Operating Expenses over 5 years: stood at $78509.0 in 2022, then declined by 0.0% to $78507.0 in 2023, then jumped by 370.9% to $369687.0 in 2024, then retreated by 23.92% to $281246.0 in 2025, then fell by 25.33% to $210016.0 in 2026.
- Business Quant data shows RTGN's Other Operating Expenses at $210016.0 in Q1 2026, $281246.0 in Q4 2025, and $277226.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.86 Bn | 175.56 Bn | 6.27 Bn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn |
| 3 | Medtronic | 108.31 Bn | 99.09 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.46 Bn | 67.01 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.25 Bn | 44.58 Bn | 1.29 Bn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.05 Bn | 25.76 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.96 Bn | 26.38 Bn | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 210,016.00 |
| Dec 31, 2025 | 281,246.00 |
| Sep 30, 2025 | 277,226.00 |
| Jun 30, 2025 | 250,189.00 |
| Mar 31, 2025 | 231,933.00 |
| Dec 31, 2024 | 369,687.00 |
| Sep 30, 2024 | 296,256.00 |
| Jun 30, 2024 | 211,009.00 |
| Mar 31, 2024 | 1.73 Mn |
| Dec 31, 2023 | 78,507.00 |
| Sep 30, 2023 | 428,683.00 |
| Jun 30, 2023 | 78,509.00 |
| Mar 31, 2023 | 78,509.00 |
| Dec 31, 2022 | 78,509.00 |
| Sep 30, 2022 | 2.10 Mn |
| Jun 30, 2022 | 55,051.00 |
| Mar 31, 2022 | 55,051.00 |
| Dec 31, 2021 | -319,685.00 |
| Sep 30, 2021 | 55,051.00 |
| Jun 30, 2021 | 86,329.00 |